234 related articles for article (PubMed ID: 15683602)
1. Inflammation as a mechanism and therapeutic target for in-stent restenosis.
Drachman DE; Simon DI
Curr Atheroscler Rep; 2005 Feb; 7(1):44-9. PubMed ID: 15683602
[TBL] [Abstract][Full Text] [Related]
2. Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects.
Li JJ; Li J; Nan JL; Li Z; Zhen X; Mu CW; Dai J; Zhang CY
Med Hypotheses; 2007; 69(5):1004-9. PubMed ID: 17499449
[TBL] [Abstract][Full Text] [Related]
3. Prevention of restenosis after stenting: the emerging role of inflammation.
Versaci F; Gaspardone A
Coron Artery Dis; 2004 Sep; 15(6):307-11. PubMed ID: 15346087
[TBL] [Abstract][Full Text] [Related]
4. Is inflammation a contributor for coronary stent restenosis?
Li JJ; Nie SP; Zhang CY; Gao Z; Zheng X; Guo YL
Med Hypotheses; 2007; 68(5):945-51. PubMed ID: 17045418
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone and restenosis after coronary stent implantation: new indication for an old drug?
Radke PW; Weber C; Kaiser A; Schober A; Hoffmann R
Curr Pharm Des; 2004; 10(4):349-55. PubMed ID: 14965196
[TBL] [Abstract][Full Text] [Related]
6. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of drug-eluting stents: the next revolution.
Moses JW; Kipshidze N; Leon MB
Am J Cardiovasc Drugs; 2002; 2(3):163-72. PubMed ID: 14727979
[TBL] [Abstract][Full Text] [Related]
8. [Stents in interventional cardiology].
Grinius V; Navickas R; Unikas R
Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
[TBL] [Abstract][Full Text] [Related]
9. Can angiotensin receptor antagonists prevent restenosis after stent placement?
Peters S
Am J Cardiovasc Drugs; 2002; 2(3):143-8. PubMed ID: 14727976
[TBL] [Abstract][Full Text] [Related]
10. "High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation: A randomized controlled trial evaluating the relationship to endothelial function and inflammation." Am Heart J 2009;158:734-41.
Meyer P; Gayda M; Normandin E; Guiraud T; Juneau M; Nigam A
Am Heart J; 2010 Mar; 159(3):e21. PubMed ID: 20211291
[No Abstract] [Full Text] [Related]
11. Current status of intravascular stents as delivery devices to prevent restenosis.
Pearce BJ; McKinsey JF
Vasc Endovascular Surg; 2003; 37(4):231-7; discussion 237. PubMed ID: 12894364
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.
Kuchulakanti P; Waksman R
Drugs; 2004; 64(21):2379-88. PubMed ID: 15481997
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stent: the emerging technique for the prevention of restenosis.
Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
Curcio A; Torella D; Indolfi C
Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
[TBL] [Abstract][Full Text] [Related]
15. The forgotten player of in-stent restenosis: endothelial dysfunction.
Celik T; Iyisoy A; Kursaklioglu H; Celik M
Int J Cardiol; 2008 Jun; 126(3):443-4. PubMed ID: 17466392
[TBL] [Abstract][Full Text] [Related]
16. Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems.
Kavanagh CA; Rochev YA; Gallagher WM; Dawson KA; Keenan AK
Pharmacol Ther; 2004 Apr; 102(1):1-15. PubMed ID: 15056495
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of restenosis and drug-eluting stents.
Costa MA; Simon DI
Circulation; 2005 May; 111(17):2257-73. PubMed ID: 15867193
[No Abstract] [Full Text] [Related]
18. Inflammation and restenosis: implications for therapy.
Donners MM; Daemen MJ; Cleutjens KB; Heeneman S
Ann Med; 2003; 35(7):523-31. PubMed ID: 14649334
[TBL] [Abstract][Full Text] [Related]
19. In-stent coronary restenosis, but not the type of stent, is associated with impaired endothelial-dependent vasodilatation.
Mizia-Stec K; Gasior Z; Haberka M; Mizia M; Chmiel A; Janowska J; Holecki M; Mielczarek M; Zahorska-Markiewicz B
Kardiol Pol; 2009 Jan; 67(1):9-17; discussion 18. PubMed ID: 19253185
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting.
Kiernan TJ; Yan BP; Cruz-Gonzalez I; Cubeddu RJ; Caldera A; Kiernan GD; Gupta V
Cardiovasc Hematol Agents Med Chem; 2008 Apr; 6(2):116-24. PubMed ID: 18473776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
